ViiV Healthcare announces positive Week 48 results in first study to evaluate treatment switch from TAF-containing regimen with three or more drugs to 2-drug regimen of dolutegravir/lamivudine for HIV-1 infection - Business Wire

ViiV Healthcare announces positive Week 48 results in first study to evaluate treatment switch from TAF-containing regimen with three or more drugs to 2-drug regimen of dolutegravir/lamivudine for HIV-1 infection  Business Wire

Data from the TANGO study presented at the 10th International AIDS Society Conference on HIV Science (IAS 2019) demonstrate non-inferior efficacy of ...



Comments

Popular posts from this blog

The Best Flea Treatments for Cats and Dogs

Everything You Need to Know About Mite and Flea Bites

Is Citronella Safe for Dogs? A Veterinarian Provides Guidance